Johnson & Johnson (JNJ) FY2025 Q1 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2024-12-30 to 2025-03-30

Swipe to see the full flow
Johnson & Johnson cash flow reconciliation, Dec 30, 2024 through Mar 30, 2025One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net earnings → Net cash from operating activities: $4,174,000,000.00Net earnings → Operating adjustments reconciliation: $6,825,000,000.00Deferred tax provision → Operating adjustments reconciliation: $2,172,000,000.00Depreciation and amortization of property and intangibles → Operating adjustments reconciliation: $1,772,000,000.00Stock based compensation → Operating adjustments reconciliation: $288,000,000.00Asset write-downs → Operating adjustments reconciliation: $30,000,000.00Charges for purchase of in-process research and development assets → Operating adjustments reconciliation: $16,000,000.00Operating adjustments reconciliation → Decrease in other current and non-current liabilities: $6,509,000,000.00Operating adjustments reconciliation → Decrease in accounts payable and accrued liabilities: $2,126,000,000.00Operating adjustments reconciliation → (Increase)/Decrease in other current and non-current assets: $1,317,000,000.00Operating adjustments reconciliation → Increase in accounts receivable: $926,000,000.00Operating adjustments reconciliation → Increase in inventories: $146,000,000.00Operating adjustments reconciliation → Net gain on sale of assets/businesses: $75,000,000.00Operating adjustments reconciliation → Credit losses and accounts receivable allowances: $4,000,000.00Proceeds from long-term debt, net of issuance costs → financing reconciliation: $9,138,000,000.00Proceeds from short-term debt, net → financing reconciliation: $8,784,000,000.00Proceeds from the exercise of stock options/employee withholding tax on stock awards, net → financing reconciliation: $450,000,000.00Other → financing reconciliation: $40,000,000.00financing reconciliation → Net cash from financing activities: $10,422,000,000.00financing reconciliation → Dividends to shareholders: $2,989,000,000.00financing reconciliation → Repurchase of common stock: $2,127,000,000.00financing reconciliation → Repayment of short-term debt, net: $2,120,000,000.00financing reconciliation → Repayment of long-term debt: $751,000,000.00financing reconciliation → Credit support agreements activity, net: $3,000,000.00Net cash used in investing activities → investing reconciliation: $297,000,000.00Credit support agreements activity, net → investing reconciliation: $296,000,000.00Proceeds from the disposal of assets/businesses, net (Note 10) → investing reconciliation: $279,000,000.00Sales of investments → investing reconciliation: $218,000,000.00investing reconciliation → Additions to property, plant and equipment: $795,000,000.00investing reconciliation → Purchases of investments: $251,000,000.00investing reconciliation → Other (including capitalized licenses and milestones): $30,000,000.00investing reconciliation → Acquired in-process research and development assets (Note 10): $14,000,000.00Exchange-rate effect → Cash sources and uses: $70,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $24,105,000,000.00Net cash from operating activities → Cash sources and uses: $4,174,000,000.00Net cash from financing activities → Cash sources and uses: $10,422,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $38,474,000,000.00Cash sources and uses → Net cash used in investing activities: $297,000,000.00Net earnings: $10,999,000,000.00Net earnings+$11.00 BDepreciation and amortization of property and intangibles: $1,772,000,000.00Depreciation & amortization+$1.77 BStock based compensation: $288,000,000.00Stock-based compensation+$288.00 MAsset write-downs: $30,000,000.00Asset impairments+$30.00 MNet gain on sale of assets/businesses: -$75,000,000.00Asset sales & impairments−$75.00 MDeferred tax provision: $2,172,000,000.00Deferred income taxes+$2.17 BCredit losses and accounts receivable allowances: -$4,000,000.00Credit loss provision−$4.00 MIncrease in accounts receivable: -$926,000,000.00Accounts receivable−$926.00 MIncrease in inventories: -$146,000,000.00Inventories−$146.00 MDecrease in accounts payable and accrued liabilities: -$2,126,000,000.00Payables & accrued liabilities−$2.13 B(Increase)/Decrease in other current and non-current assets: -$1,317,000,000.00Other operating assets−$1.32 BDecrease in other current and non-current liabilities: -$6,509,000,000.00Other operating liabilities−$6.51 BCharges for purchase of in-process research and development assets: $16,000,000.00Acquired in-process R&D charges+$16.00 MNet cash from operating activities: $4,174,000,000.00Operating cash+$4.17 BOperating adjustments reconciliation: $11,103,000,000.00Repayment of long-term debt: -$751,000,000.00Senior debt repaid−$751.00 MOther: $40,000,000.00Other financing, net+$40.00 MRepurchase of common stock: -$2,127,000,000.00Common stock repurchases−$2.13 BProceeds from short-term debt, net: $8,784,000,000.00Short-term debt issued+$8.78 BCredit support agreements activity, net: -$3,000,000.00Credit support activity, net−$3.00 MRepayment of short-term debt, net: -$2,120,000,000.00Short-term debt repaid−$2.12 BProceeds from long-term debt, net of issuance costs: $9,138,000,000.00Long-term debt issued+$9.14 BDividends to shareholders: -$2,989,000,000.00Ordinary dividends paid−$2.99 BProceeds from the exercise of stock options/employee withholding tax on stock awards, net: $450,000,000.00Option & withholding tax, net+$450.00 MNet cash from financing activities: $10,422,000,000.00Financing cash+$10.42 Bfinancing reconciliation: $18,412,000,000.00Proceeds from the disposal of assets/businesses, net (Note 10): $279,000,000.00Asset sales+$279.00 MSales of investments: $218,000,000.00Investment sales & maturities+$218.00 MAdditions to property, plant and equipment: -$795,000,000.00PP&E purchases−$795.00 MAcquired in-process research and development assets (Note 10): -$14,000,000.00Acquired R&D & milestones−$14.00 MAcquisitions, net of cash acquired (Note 10): $0.00Credit support agreements activity, net: $296,000,000.00Credit support activity, net+$296.00 MPurchases of investments: -$251,000,000.00Investment purchases−$251.00 MOther (including capitalized licenses and milestones): -$30,000,000.00Other investing, net−$30.00 MNet cash used in investing activities: -$297,000,000.00. Cash required to fund net payments.Investing cash−$297.00 Minvesting reconciliation: $1,090,000,000.00Cash sources and uses: $38,771,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $24,105,000,000.00Beginning cash$24.11 BEnding cash: Cash, cash equivalents, and restricted cash: $38,474,000,000.00Ending cash$38.47 BExchange-rate effect: $70,000,000.00FX effect+$70.00 MCASH RECONCILIATIONOperatingflowsFinancingflowsInvestingflowsFree cash flow$3.38 BOperating cash − cash spent on PP&ECash flow / Net income0.38×Operating cash flow ÷ net incomeNet cash change+$14.37 BEnding cash − beginning cash
Chart details

Johnson & Johnson cash flow reconciliation, Dec 30, 2024 through Mar 30, 2025

Cash flows for Dec 30, 2024 through Mar 30, 2025. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 29, 2024. Ending cash: Mar 30, 2025. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 29, 2024
24,105,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
4,174,000,000 US dollars. Net cash provided.
Net earnings
10,999,000,000 US dollars
Depreciation and amortization of property and intangibles
1,772,000,000 US dollars
Stock based compensation
288,000,000 US dollars
Asset write-downs
30,000,000 US dollars
Net gain on sale of assets/businesses
negative 75,000,000 US dollars
Deferred tax provision
2,172,000,000 US dollars
Credit losses and accounts receivable allowances
negative 4,000,000 US dollars
Increase in accounts receivable
negative 926,000,000 US dollars
Increase in inventories
negative 146,000,000 US dollars
Decrease in accounts payable and accrued liabilities
negative 2,126,000,000 US dollars
(Increase)/Decrease in other current and non-current assets
negative 1,317,000,000 US dollars
Decrease in other current and non-current liabilities
negative 6,509,000,000 US dollars
Charges for purchase of in-process research and development assets
16,000,000 US dollars
Investing activities
negative 297,000,000 US dollars. Net cash used.
Proceeds from the disposal of assets/businesses, net (Note 10)
279,000,000 US dollars
Sales of investments
218,000,000 US dollars
Additions to property, plant and equipment
negative 795,000,000 US dollars
Acquired in-process research and development assets (Note 10)
negative 14,000,000 US dollars
Acquisitions, net of cash acquired (Note 10)
0 US dollars
Credit support agreements activity, net
296,000,000 US dollars
Purchases of investments
negative 251,000,000 US dollars
Other (including capitalized licenses and milestones)
negative 30,000,000 US dollars
Financing activities
10,422,000,000 US dollars. Net cash provided.
Repayment of long-term debt
negative 751,000,000 US dollars
Other
40,000,000 US dollars
Repurchase of common stock
negative 2,127,000,000 US dollars
Proceeds from short-term debt, net
8,784,000,000 US dollars
Credit support agreements activity, net
negative 3,000,000 US dollars
Repayment of short-term debt, net
negative 2,120,000,000 US dollars
Proceeds from long-term debt, net of issuance costs
9,138,000,000 US dollars
Dividends to shareholders
negative 2,989,000,000 US dollars
Proceeds from the exercise of stock options/employee withholding tax on stock awards, net
450,000,000 US dollars
Operating adjustment reconciliation
11,103,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
18,412,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
1,090,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
70,000,000 US dollars
Ending cash on Mar 30, 2025
38,474,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
38,771,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
14,369,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
0.38×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
4,174,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
795,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
3,379,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income exceeds operating cash. The diagram allocates $4.17B of net income directly to operating cash and $6.83B to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 4,174,000,000 US dollars minus 795,000,000 US dollars equals 3,379,000,000 US dollars.
Johnson & Johnson (JNJ) FY2025 Q1 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!